5 completed, 2 terminated, 2 unknown, 1 recruiting. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow VAP-cyclo protocol: new trials by email Literature Review of VAP-cyclo protocol trials Research Report on VAP-cyclo protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) linperlisib combined with CHOP regimen - Nodal T-follicular Helper Cell Lymphoma | Phase 2 | Recruiting | Peking University | 54 | 2023-11-28 | 2024-04-04 |
| Go-CHOP as the Frontline Therapy for PTCL Golidocitinib, CHOP Regimen - Peripheral T Cell Lymphoma | Phase 2 | Unknown | Henan Cancer Hospital | 45 | 2023-08-03 | 2023-09-01 |
| Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients Obinutuzumab, Ibrutinib, CHOP - Richter Syndrome | Phase 2 | Terminated | Northwell Health | 3 | 2017-06-19 | 2023-06-01 |
| High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk Rituximab and CHOP regimen + PBSCT - HIV-related Lymphoma, HIV Infections | Phase 2 | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 27 | 2007-01-01 | 2016-08-19 |
| Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma CHOP regimen, cyclophosphamide, doxorubicin hydrochloride - Lymphoma, Small Intestine Cancer | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 25 | 2004-01-01 | 2012-09-24 |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma CHOP regimen, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 3 | 2003-03-01 | 2012-09-24 |
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL filgrastim, rituximab, CHOP regimen - Leukemia | Phase 2 | Completed | Swiss Cancer Institute | 43 | 2002-06-01 | 2012-05-15 |
| S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma CHOP regimen, cyclophosphamide, doxorubicin hydrochloride - Lymphoma | Phase 2 | Completed | SWOG Cancer Research Network | 102 | 1999-05-01 | 2013-01-24 |
| Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma filgrastim, CHOP regimen, carboplatin - Lymphoma | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 24 | 1998-06-01 | 2013-06-24 |
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides CHOP regimen, doxorubicin hydrochloride, etoposide - Lymphoma | Phase 2 | Unknown | National Cancer Institute (NCI) | 3 | 1993-06-01 | 2013-12-18 |
Lymphoma (5) · Leukemia (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, T-Cell, Cutaneous (2) · HIV Infections (1) · Immunoblastic Lymphadenopathy (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, AIDS-Related (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Peripheral (1) · Mycosis Fungoides (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
European Organisation for Research and Treatment of Cancer - EORTC (2) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Henan Cancer Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · Northwell Health (1) · Peking University (1) · SWOG Cancer Research Network (1) · Swiss Cancer Institute (1)
United States (3) · Belgium (2) · China (2) · Croatia (1) · Egypt (1) · France (1) · Italy (1) · Netherlands (1) · South Africa (1) · Switzerland (1)
Carol S. Portlock, MD (1) · Giuseppe Rossi, MD (1) · Igor Aurer, MD, PhD (1) · Jacqueline Barrientos, MD (1) · Keshu Zhou, Dr. (1) · Nicolas Novitzky, MD, PhD (1) · Oliver W. Press, MD, PhD (1) · Pierre Soubeyran, MD, PhD (1) · Reinhard Zenhaeusern, MD (1)
PMID 12738671, PMID 16896003, PMID 20218808, PMID 20942843
U10CA032102 (1)